These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 22530301

  • 21. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.
    Yüksel N, Karataş A, Ozkan Y, Savaşer A, Ozkan SA, Baykara T.
    Eur J Pharm Biopharm; 2003 Nov; 56(3):453-9. PubMed ID: 14602190
    [Abstract] [Full Text] [Related]

  • 22. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A, Bekmezci S.
    Acta Pol Pharm; 2013 Nov; 70(5):883-97. PubMed ID: 24147368
    [Abstract] [Full Text] [Related]

  • 23. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol.
    Karataş A, Yüksel N, Baykara T.
    Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514
    [Abstract] [Full Text] [Related]

  • 24. Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
    Tung NT, Tran CS, Nguyen HA, Nguyen TD, Chi SC, Pham DV, Bui QD, Ho XH.
    Int J Pharm; 2019 Jan 30; 555():63-76. PubMed ID: 30448315
    [Abstract] [Full Text] [Related]

  • 25. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
    Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG.
    Drug Deliv; 2010 Jul 30; 17(5):322-9. PubMed ID: 20367177
    [Abstract] [Full Text] [Related]

  • 26. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
    Yanyu X, Yunmei S, Zhipeng C, Qineng P.
    Int J Pharm; 2006 Jan 03; 307(1):77-82. PubMed ID: 16300915
    [Abstract] [Full Text] [Related]

  • 27. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH, Bandari S, Jukanti R, Veerareddy PR.
    Arch Pharm Res; 2011 Jan 03; 34(1):51-7. PubMed ID: 21468915
    [Abstract] [Full Text] [Related]

  • 28. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q.
    Colloids Surf B Biointerfaces; 2010 Oct 15; 80(2):213-8. PubMed ID: 20621458
    [Abstract] [Full Text] [Related]

  • 29. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J.
    Drug Dev Ind Pharm; 2015 May 15; 41(5):772-9. PubMed ID: 24669978
    [Abstract] [Full Text] [Related]

  • 30. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.
    Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP, Jemal M, Bathala MS, Varia SA, Serajuddin AT.
    Int J Pharm; 2004 Jan 09; 269(1):251-8. PubMed ID: 14698596
    [Abstract] [Full Text] [Related]

  • 31. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM, Kellaway IW, Murdan S.
    J Pharm Pharmacol; 2006 Oct 09; 58(10):1319-26. PubMed ID: 17034654
    [Abstract] [Full Text] [Related]

  • 32. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J, Hou SX, Feng JF, Cai BQ.
    Zhongguo Zhong Yao Za Zhi; 2005 Nov 09; 30(21):1651-3. PubMed ID: 16400939
    [Abstract] [Full Text] [Related]

  • 33. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules.
    Hannula AM, Marvola M, Rajamaeki M, Ojantakanen S.
    Eur J Drug Metab Pharmacokinet; 1991 Nov 09; Spec No 3():221-7. PubMed ID: 1820883
    [Abstract] [Full Text] [Related]

  • 34. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
    Crum M, Elkordy AA, Zarara M, Elkordy EA.
    Pharm Dev Technol; 2013 Nov 09; 18(6):1379-90. PubMed ID: 22992055
    [Abstract] [Full Text] [Related]

  • 35. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N, Katare OP, Singh B.
    Eur J Pharm Biopharm; 2007 Jan 09; 65(1):26-38. PubMed ID: 16962750
    [Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F, Ozcan I, Guneri T.
    Drug Deliv; 2010 Apr 09; 17(3):152-7. PubMed ID: 20148713
    [Abstract] [Full Text] [Related]

  • 37. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.
    Feng BL, Li HW, Zhou MY, Lu W.
    Zhong Yao Cai; 2011 Apr 09; 34(4):605-10. PubMed ID: 21809547
    [Abstract] [Full Text] [Related]

  • 38. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
    Baek HH, Kwon SY, Rho SJ, Lee WS, Yang HJ, Hah JM, Choi HG, Kim YR, Yong CS.
    Arch Pharm Res; 2011 Mar 09; 34(3):391-7. PubMed ID: 21547670
    [Abstract] [Full Text] [Related]

  • 39. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 09; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 40. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
    Cao X, Fu M, Wang L, Liu H, Deng W, Qu R, Su W, Wei Y, Xu X, Yu J.
    Acta Biomater; 2012 Jul 09; 8(6):2104-12. PubMed ID: 22343518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.